Ledger.Open graph →
SEC Form D · Amendment · filed March 29, 2019

LifeMine Therapeutics, Inc

Offering
$70.1M
Sold
$70.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Yanling L. Cao · Cambridge, MADirectorGregory L. Verdine · Cambridge, MAExec · DirectorWei L. Li · Cambridge, MADirectorKaiwalya Kher · San Francisco, CADirectorJonathan N. Abe · CAMBRIDGE, MAExec · DirectorRichard L. Klausner · Cambridge, MADirectorTravis J. Putnam · Los Angeles, CAExecMichael Bach · San Francisco, CADirectorWei L. Li · Cambridge, MADirectorKrishna L. Yeshwant · Cambridge, MADirectorOmar N. Blayton · CAMBRIDGE, MADirectorRich Levandov · San Francisco, CAExecWeiqing L. Zhou · Cambridge, MAExecBrady Bohrmann · San Francisco, CAExec · DirectorRichard L. Klausner · Cambridge, MADirectorHelen Thornton · Hamilton, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗